Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin In Patients With Fibromyalgia.

PHASE3CompletedINTERVENTIONAL
Enrollment

747

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Fibromyalgia
Interventions
DRUG

pregabalin

600mg/day

DRUG

pregabalin

450mg/day

DRUG

pregabalin

300mg/day

DRUG

placebo

placebo

Trial Locations (74)

1010

Pfizer Investigational Site, Caracas

1011

Pfizer Investigational Site, Lausanne

1060

Pfizer Investigational Site, Caracas

1081

Pfizer Investigational Site, Caracas

2000

Pfizer Investigational Site, Frederiksberg

2502

Pfizer Investigational Site, Warrawong

3065

Pfizer Investigational Site, Fitzroy

3168

Pfizer Investigational Site, Clayton

4558

Pfizer Investigational Site, Maroochydore

5700

Pfizer Investigational Site, Svendborg

8063

Pfizer Investigational Site, Zurich

8091

Pfizer Investigational Site, Zurich

10117

Pfizer Investigational Site, Berlin

14004

Pfizer Investigational Site, Córdoba

14080

Pfizer Investigational Site, México

14109

Pfizer Investigational Site, Berlin

19002

Pfizer Investigational Site, Guadalajara

34295

Pfizer Investigational Site, Montpellier

37520

Pfizer Investigational Site, León

40138

Pfizer Investigational Site, Bologna

42055

Pfizer Investigational Site, Saint-Etienne

53105

Pfizer Investigational Site, Bonn

59037

Pfizer Investigational Site, Lille

63003

Pfizer Investigational Site, Clermont-Ferrand

64020

Pfizer Investigational Site, Monterrey

66013

Pfizer Investigational Site, Chieti Scalo

68161

Pfizer Investigational Site, Mannheim

75181

Pfizer Investigational Site, Paris

78240

Pfizer Investigational Site, San Luis Potosí City

79124

Pfizer Investigational Site, Bari

79713

Pfizer Investigational Site, Bad Säckingen

80336

Pfizer Investigational Site, München

82100

Pfizer Investigational Site, Benevento

452001

Pfizer Investigational Site, Indore

V1Y 2H4

Pfizer Investigational Site, Kelowna

R3A 1R9

Pfizer Investigational Site, Winnipeg

E2A 4X7

Pfizer Investigational Site, Bathurst

A1B 3E1

Pfizer Investigational Site, St. John's

K6A 1A1

Pfizer Investigational Site, Hawkesbury

M3K 2A7

Pfizer Investigational Site, Toronto

J2B 7T1

Pfizer Investigational Site, Drummondville

H3T 1E2

Pfizer Investigational Site, Montreal

H9R 3J1

Pfizer Investigational Site, Pointe-Claire

G1V 3M7

Pfizer Investigational Site, Québec

J1H 1Z1

Pfizer Investigational Site, Sherbrooke

J1H 5N4

Pfizer Investigational Site, Sherbrooke

141 001

Pfizer Investigational Site, Ludhiana

141 008

Pfizer Investigational Site, Ludhiana

226 014

Pfizer Investigational Site, Lucknow

06100

Pfizer Investigational Site, Perugia

Unknown

Pfizer Investigational Site, Pisa

1815 JD

Pfizer Investigational Site, Alkmaar

1782 GZ

Pfizer Investigational Site, Den Helder

8934 AD

Pfizer Investigational Site, Leeuwarden

3015 GD

Pfizer Investigational Site, Rotterdam

8011 JW

Pfizer Investigational Site, Zwolle

1050-054

Pfizer Investigational Site, Lisbon

1249-075

Pfizer Investigational Site, Lisbon

1349-019

Pfizer Investigational Site, Lisbon

1700-360

Pfizer Investigational Site, Lisbon

442-712

Pfizer Investigational Site, Suwon

133-792

Pfizer Investigational Site, Seoul

143-914

Pfizer Investigational Site, Seoul

08024

Pfizer Investigational Site, Barcelona

08035

Pfizer Investigational Site, Barcelona

581 85

Pfizer Investigational Site, Linköping

431 37

Pfizer Investigational Site, Mölndal

701 85

Pfizer Investigational Site, Örebro

SE-112 81

Pfizer Investigational Site, Stockholm

M6 8HD

Pfizer Investigational Site, Manchester

PA16 0XN

Pfizer Investigational Site, Greenock

NE29 8NH

Pfizer Investigational Site, North Shields

WC1X 8LD

Pfizer Investigational Site, London

BH12 2JB

Pfizer Investigational Site, Poole

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00333866 - Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin In Patients With Fibromyalgia. | Biotech Hunter | Biotech Hunter